SATB2-Associated Syndrome Due to a c.715C>T:p(Arg239*) Variant in Adulthood: Natural History and Literature Review

Genes (Basel). 2023 Apr 8;14(4):882. doi: 10.3390/genes14040882.

Abstract

SATB2-associated syndrome (SAS) is a rare condition, and it is characterized by severe developmental delay/intellectual disability, especially severe speech delay/or absence, craniofacial abnormalities, and behavioral problems. Most of the published reports are limited to children, with little information about the natural history of the disease and the possible novel signs and symptoms or behavioral changes in adulthood. We describe the management and follow-up of a 25-year-old male with SAS due to a de novo heterozygous nonsense variant SATB2:c.715C>T:p.(Arg239*) identified by whole-exome sequencing and review the literature. The case herein described contributes to a better characterization of the natural history of this genetic condition and in addition to the genotype-phenotype correlation of the SATB2:c.715C>T:p.(Arg239*) variant in SAS, highlights some particularities of its management.

Keywords: SATB2; behavior problems; cleft palate; natural history; osteopenia; whole-exome sequencing.

Publication types

  • Review
  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Genetic Association Studies
  • Humans
  • Intellectual Disability* / genetics
  • Male
  • Matrix Attachment Region Binding Proteins* / genetics
  • Phenotype
  • Syndrome
  • Transcription Factors / genetics

Substances

  • Matrix Attachment Region Binding Proteins
  • Transcription Factors
  • SATB2 protein, human

Grants and funding

This research was funded by the National Council for Scientific and Technological Development (CNPq) (#408504/2018-8 and #309782/2020-1), Coordenação de Aperfeiçoamento de Pessoal de Nível Superior—Brasil (CAPES #001) (to VLGSL), and Fonds de la Recherche Scientifique—FNRS Grant J.0228.20 (to M.V). The authors thank the Genomics Platform of the University of Louvain for the access to the Next-Generation Sequencing data analysis cluster. Eleonore Pairet is a Research Fellow (ASP) grantee of the Fonds de la Recherche Scientifique—FNRS. We also thank the National Lottery, Belgium and the Foundation Against Cancer (2010-101), Belgium for their support to the Genomics Platform of the University of Louvain and the de Duve Institute, as well as the Fonds de la Recherche Scientifique—FNRS Equipment Grant U.N035.17 for the «Big data analysis cluster for NGS at UCLouvain».